A Pilot Genome-wide Association Study of Breast Cancer Susceptibility Loci in Indonesia |
Haryono, Samuel J
(Department of Oncology, MRCCC Siloam Hospital Semanggi)
Datasena, I Gusti Bagus (Department of Oncology, MRCCC Siloam Hospital Semanggi) Santosa, Wahyu Budi (Department of Oncology, MRCCC Siloam Hospital Semanggi) Mulyarahardja, Raymond (Department of Oncology, MRCCC Siloam Hospital Semanggi) Sari, Kartika (Department of Oncology, MRCCC Siloam Hospital Semanggi) |
1 | Antoniou AC, Wang X, Fredericksen ZS, et al (2010). A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population. Nat Genet, 42, 885-92. DOI |
2 | Ahmed S, Thomas G, Ghoussaini M, et al (2009). Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat Genet, 41, 585-90. DOI |
3 | Balmain A, Gray J, Ponder B (2003). The genetics and genomics of cancer. Nat Genet, 33, 238-44. DOI |
4 | Crown Human Genome Center, Department of Molecular Genetics, the Weizmann Institute of Science. 2014. Catenin (cadherin-associated protein), alpha 2. Accessed August 2, 2014, at http://www.genecards.org/cgi-bin/carddisp.pl?gene=CTNNA2. |
5 | Crown Human Genome Center, Department of Molecular Genetics, the Weizmann Institute of Science. 2014. Testis expressed 10. Accessed August 2, 2014, at http://www.genecards.org/cgi-bin/carddisp.pl?gene=TEX10. |
6 | Easton DF, Pooley KA, Dunning AM, et al (2007). Genome-wide association study identifies novel breast cancer susceptibility loci. Nature, 447, 1087-93. DOI |
7 | Fanjul-Fernandez M, Quesada V, Cabanillas R, et al (2013). Cell-cell adhesion genes CTNNA2 and CTNNA3 are tumor suppressors frequently mutated in laryngeal carcinomas. Nat Commun, 4, 2351. |
8 | Fletcher O, Johnson N, Orr N, et al (2011). Novel breast cancer susceptibility locis at 9q31.2: results of a genome-wide association study. J Natl Cancer Inst, 103, 425-35. DOI |
9 | Gaudet MM, Kirchhoff T, Green T, et al (2010). Common genetic variants and modification of penetrance of BRCA2-associated breast cancer. PLoS Gene, 6, 1001183. DOI |
10 | Gold B, Kirchhoff T, Stefanov S, et al (2008). Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.23. Proc Natl Acad Sci USA, 105, 4340-5. DOI |
11 | Guan YP, Yang XX, Yao GY, et al (2014). Breast cancer association studies in a Han Chinese population using 10 European-ancestry-associated breast cancer susceptibility SNPs. Asian Pac J Cancer Prev, 15, 85-91. DOI |
12 | Hunter DJ, Kraft P, Jacobs KB, et al (2007). A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet, 39, 870-4. DOI |
13 | Iodice S, Barile M, Rotmensz N, et al (2010). Oral contraceptive use and breast or ovarian cancer risk in BRCA1/2 carriers: a meta-analysis. Eur J Cancer, 46, 2275-84. DOI |
14 | Islam T, Ito H, Sueta A, et al (2013). Alcohol and dietary folate intake and the risk of breast cancer: a case-control study in Japan. Eur J Cancer Prev, 22, 358-66. DOI |
15 | Kim HC, Lee JY, Sung H, et al (2012). A genome-wide association study identifies a breast cancer risk variant in ERBB4 at 2q34: results from the Seoul Breast Cancer Strudy. Breast Cancer Research, 14, 56. |
16 | Liang H, Samanta S, Nagarajan L (2005). SSBP2, a candidate tumor suppressor genem induces growth arrest and differentiation of myeloid leukemia cells. Oncogene, 24, 2625-34. DOI |
17 | Long J, Cai Q, Shu XO, et al (2010). Identification of a functional genetic variant at 16q12.1 for breast cancer risk: results from the asia breast cancer consortium. PLoS Genet, 6, 1001002. DOI |
18 | Mahdi KM, Nassiri MR, Nasiri K (2013). Hereditary genes and SNPs associated with breast cancer. Asian Pac J Cancer Prev, 14, 3403-9. DOI ScienceOn |
19 | Ng CH, Pathy NB, Taib NA, et al (2011). Comparison of breast cancer in Indonesia and Malaysia . a clinico-pathological study between Dharmais Cancer Centre Jakarta and University Malaya Medical Centre, Kuala Lumpur. Asian Pacific J Cancer Prev, 12, 2943-6. |
20 | Nathanson KL, Wosster R, Weber BL (2001). Breast cancer genetics: what we know and what we need. Nat Med, 7, 552-6. DOI |
21 | Phipps AI, Chlebowski RT, Prentice R, et al (2011). Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer. J Natl Cancer Inst, 103, 1-8. DOI |
22 | Stacey SN, Manolescu A, Sulem P, et al (2007). Common variants on chromosome 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet, 39, 865-9. DOI |
23 | Stacey SN, Manolescu A, Sulem P, et al (2008). Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet, 40, 703-6. DOI ScienceOn |
24 | Shu XO, Long J, Lu W, et al (2012). Novel genetic markers of breast cancer survival identified by a genome-wide association study. Cancer Res, 72, 1182-9. DOI |
25 | The National Center for Biotechnology Information. 2014. CTNNA2 catenin (cadherin-associated protein), alpha 2. Accessed August 2, 2014, at http://www.ncbi.nlm.nih.gov/gene/1496. |
26 | The National Center for Biotechnology Information. 2014. MTCL1 microtubule crosslinking factor 1. Accessed August 2, 2014, at http://www.ncbi.nlm.nih.gov/gene/23255. |
27 | The National Center for Biotechnology Information. 2014. SSBP2 single-stranded DNA binding protein 2. Accessed August 2, 2014, at http://www.ncbi.nlm.nih.gov/gene/23635. |
28 | Tjindarbumi D, Mangunkusumo R (2002). Cancer in Indonesia, present and future. Jpn J Clin Oncol, 32, 17-21. DOI |
29 | The National Center for Biotechnology Information. 2014. TEX10 testis expressed 10. Accessed August 2, 2014, at http://www.ncbi.nlm.nih.gov/gene/54881. |
30 | Thomas G, Jacobs KB, Kraft P, et al (2009). A multi-stage genome-wide association in breast cancer identifies two novel risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat Genet, 41, 579-84. DOI |
31 | Turnbull C, Ahmed S, Morrison J, et al (2010). Genome-wide association study identifies five new breast cancer susceptibility loci. Nat Genet, 42, 504-7. DOI ScienceOn |
32 | Xiao Y, Decker PA, Rice T, et al (2012). SSBP2 variants are associated with survival in glioblastoma patients. Clin Cancer Res, 18, 3154-62. DOI |
33 | Yoshitake H, Yokoi H, Ishikawa H, et al (2012). Overexpression of TEX10, a potential novel cancer marker, in head and neck squamous cell carcinoma. Cancer Biomark, 12, 141-8. |
34 | Zhang B, Beeghly-fadiel A, Long J, et al (2011). Genetic variants associated with breast-cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence. Lancet Oncol, 12, 477-88. DOI |
35 | Zheng W, Long J, Gao YT, et al (2009). Genome-wide association study identifies a novel breast cancer susceptibility locus at 6q25.1. Nat Genet, 41, 324-8. DOI |
36 | Zheng W, Cai Q, Signorello LB, et al (2009). Evaluation of 11 breast cancer susceptibility loci in African-American women. Cancer Epidemiol Biomarkers Prev, 18, 2761-4. DOI |
37 | Zheng W, Wen W, Gao YT, et al (2010). Genetic and clinical predictors for breast cancer risk assessment and stratification among Chinese women. J Natl Cancer Inst, 102, 972-81. DOI |